0001004878-17-000117.txt : 20170512
0001004878-17-000117.hdr.sgml : 20170512
20170512172217
ACCESSION NUMBER: 0001004878-17-000117
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20170512
ITEM INFORMATION: Other Events
ITEM INFORMATION: Financial Statements and Exhibits
FILED AS OF DATE: 20170512
DATE AS OF CHANGE: 20170512
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
FILING VALUES:
FORM TYPE: 8-K
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 17839995
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
8-K
1
form8kitem801may-17.txt
FORM 8-K ITEM 8.01
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 12, 2017
CEL-SCI CORPORATION
-------------------------------------
(Exact name of Registrant as specified in its charter)
Colorado 001-11889 84-0916344
-------------------- ------------------ -----------------
(State or other jurisdiction (Commission File No.) (IRS Employer
of incorporation) Identification No.)
8229 Boone Boulevard, Suite 802
Vienna, Virginia 22182
-------------------------------------
(Address of principal executive offices, including Zip Code)
Registrant's telephone number, including area code: (703) 506-9460
N/A
------------------------------
(Former name or former address if changed since last report)
Item 8.01 Other Events
On May 12, 2017 the Company issued a press release, filed as Exhibit 99,
regarding the rescheduling of its annual meeting of shareholders to June 12,
2017.
Item 9.01 Exhibits
Exhibit
Number Description of Document
------ -----------------------
99 May 12, 2017 Press Release.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Date: May 12, 2017 CEL-SCI CORPORATION
By: /s/ Patricia B. Prichep
--------------------------------------
Patricia B. Prichep
Senior Vice President of Operations
EX-99
2
form8kitem801ex99may-17.txt
EXHIBIT 99 PRTESS RELEASE
EXHIBIT 99
8229 Boone Boulevard, Suite 802 COMPANY CONTACT:
Vienna, VA 22182. USA Gavin de Windt
Telephone (703) 506-9460 CEL-SCI Corporation
www.cel-sci.com (703) 506-9460
CEL-SCI ANNOUNCES CHANGE TO THE DATE OF ITS ANNUAL MEETING
Vienna, VA, Friday, May 12, 2017 - CEL-SCI Corporation (NYSE MKT: CVM) today
announced it has changed the date for its annual meeting from June 9, 2017 to
June 12, 2017.
The Company's annual meeting is now scheduled for Monday, June 12, 2017 at 10:30
a.m. local time. The meeting will be held at 4820-C Seton Drive, Baltimore, MD
21215. No changes have been made to the record date or the proposals to be
brought before the annual meeting, which are presented in the Proxy Statement
that the Company filed with the Securities and Exchange Commission (SEC) on
April 27, 2017. Stockholders who have already submitted a proxy or voting
instructions do not need to take any further action.
The Company's Proxy Statement and Annual Report filed by the Company with the
SEC are available on the SEC's website at http://www.sec.gov.
About CEL-SCI Corporation
CEL-SCI's work is focused on finding the best way to activate the immune system
to fight cancer and infectious diseases. The Company has operations in Vienna,
Virginia, and in/near Baltimore, Maryland.